low-up clinical data at 3, 6, and 12 months after the onset of AMI and annually thereafter. We obtained data concerning subsequent cardiac events by visits to the research outpatient clinic or, in a few instances, by verbal or written contact with the patient's physician, the patient, or family members.
Obesity was defined as body mass index ≥25 kg/m 2 . Diabetes mellitus was defined as a fasting plasma glucose concentration ≥126 mg/dl or the use of antidiabetic therapy. Hypertension was defined as a history of a systolic blood pressure ≥140 mmHg, a diastolic blood pressure ≥90 mmHg, or the use of antihypertensive therapy. Hyperlipidemia was defined as a fasting total cholesterol concentration ≥220 mg/dl, a fasting triglyceride concentration ≥150 mg/dl, or the use of antihyperlipidemic therapy. Renal failure was defined as serum creatinine concentration ≥2.0 mg/dl. To determine the peak creatine kinase and glutamate oxaloacetate transaminase concentrations, blood samples were taken immediately after admission and at 6, 12, 18, 24, 36, 48 h later.
Statistical Analysis
Time intervals are presented as median times and interquartile range. Other continuous variables are presented as mean ± standard deviation. Continuous variables between groups were compared by t-test. The monthly, weekly, and circadian distributions of the onset of AMI were first tested for homogeneity by chi-square goodness-of-fit test. When this test showed significant differences, a one-sided binominal test was performed to examine whether the frequency of AMI was higher than the expected rate. A multiple logistic regression model was used to analyze factors influencing the probability of undergoing PCI. Cox regression analysis was used for assessing the relative hazard of events. Analyses of data were performed using SPSS statistical software (SPSS version 11.0, SPSS Japan Inc, Tokyo, Japan). For all analyses, significance was defined as p<0.05.
Results

Baseline Characteristics
Overall, 18.1% of patients were obese, 24.8% had diabetes mellitus, 48.3% had hypertension and 29.3% had hyperlipidemia (Table 1) . To clarify the frequency of a cluster of risk factors (ie, obesity, hypertension, diabetes mellitus, and dyslipidemia), the number of risk factors, from 0 to 4, was investigated: approximately 70% of patients had at least 1 risk factor, and 2.1% had 4 risk factors.
Clinical Characteristics in Onset and on Admission
Significant monthly trends in the onset of AMI were seen in the total study population (chi-square test, p=0.003). Most patients were hospitalized in February (one-sided binominal test, p<0.001) and fewest in July and November (one-sided binominal test, p=0.049). There was also a significant seasonal variation (chi-square test, p=0.005) with a maximum incidence of AMI in winter (one-sided binominal test, p<0.001) and a minimum in summer (onesided binominal test, p=0.033). The distribution of the day of onset of AMI showed no significant variation for all subjects (chi-square test, p=0.599), indicating that the distribution was fairly random in this community as a whole. Significant circadian distributions were seen in this study population (p=0.006), with 2 peaks around 10.00 and 21.00 h, respectively. When distribution of the onset of AMI was obtained for 4-h intervals, the morning peak between 8.00 and 11.59 h was statistically significant (p<0.001), but not the nighttime peak between 20.00 and 23.59 h (p=0.131).
The dominant presenting symptoms in the total study population were chest pain (92.8%), dyspnea (8.9%), vomiting (10.4%) and syncope (4.1%). In approximately 50%, the index AMI was preceded by chest pain episodes, 40% had an AMI after exertion and 59.6% of patients had an AMI at rest. The median delay between symptom onset and hospital arrival was 2.0 h (interquartile range 1.0-6.0 h): 78% of patients arrived within 6 h.
In-Hospital Reperfusion Treatments and Outcomes
In the total study population, 68.7% of patients received reperfusion therapies: thrombolysis was used in 33.7%, PCI in 45.8%, and coronary artery bypass grafting in 3.1%. Table 2 shows factors independently associated with the use of PCI. Men and the registry year had a positive association with the use of primary PCI. The proportion of PCI cases was more frequent in men than in women (50.0% vs 32.7%, p=0.002) and significantly increased from 6.7% in 1989 to 72.2% in 2002 (p<0.001). Increased age was negatively associated with the probability of undergoing PCI: the proportion of PCI in patients ≥70 years tended to be lower than that in patients less than 70 (40.3% vs 48.9%, p=0.091). Table 3 shows in-hospital outcomes: 9.7% of patients died before hospital discharge, and 3.2% had a nonfatal re-infarction. Congestive heart failure occurred in 16.9% of patients, mechanical complications in 1.5%, recurrent ischemia in 15.4%, and fatal arrhythmia in 23.3%.
Long-Term Mortality Rate
During the follow-up period (mean duration, 4.01±3.41 years), 89 patients died: 64 cardiovascular deaths. The unadjusted long-term all-cause mortality and cardiac mortality rates were 21.4% and 15.4%, respectively (Fig 1) . Multivariate Cox regression analysis showed that age, prior cerebrovascular disease, renal failure, use of PCI, Killip ≥2, and ventricular tachycardia/fibrillation were independent predictors of long-term all-cause mortality (Table 4) . A subgroup analysis was made according to predictors for the use of PCI (Fig 2) . In men and women, as well as younger and older patients, PCI was significantly associated with favorable long-term mortality rates. PCI was an independent predictor of favorable long-term survival in patients who were registered from 1996 to 2002, but not in patients who were registered from 1988 to 1995, which may reflect the low rate of PCI (19.0%) in patients who were registered during that earlier period.
Discussion
The present study revealed the following 4 points: (1) a marked seasonal variation of the onset of AMI, as well as a marked circadian variation; (2) increased age and female sex were negatively associated with the probability of undergoing PCI, even though PCI was the most common reperfusion therapy; (3) the unadjusted long-term all-cause mortality rate was 21.4% during the follow-up period; (4) multivariate Cox regression analysis showed that age, prior cerebrovascular disease, renal failure, Killip ≥2, and ventricular tachycardia/fibrillation are independent predictors of worse long-term mortality rates after AMI, whereas the use of PCI was independently associated with favorable long-term mortality rates.
Seasonal, Weekly, and Circadian Variation of AMI
The onset of AMI has a seasonal variation with a winter peak, [10] [11] [12] and it is hypothesized that exposure to winter weather conditions may induce physiologic stresses, including sympathetic activation, hypercoagulability, and infection that increase the incidence of AMI. 13 The present study showed a seasonal pattern in Japan, characterized by a marked peak of cases in the winter months, which suggests that exposure to cold temperature may trigger an AMI. Previous studies have shown that the time of onset of AMI has a circadian variation with a definite morning peak, [14] [15] [16] [17] associated with inherent biologic rhythms such as the morning surge of blood pressure, [18] [19] [20] neurohumoral factors, 21, 22 and platelet aggregability, [23] [24] [25] and a vague evening peak 16, 17 that is suggested to be associated with socioeconomic factors such as timing of the evening meal, 26 mental stress, [27] [28] [29] and overtime work. 30 However, in the present study there was a morning peak but not an evening one. Because our study population had a high frequency of older patients, we speculate that there was a low frequency of workers. Although it is impossible from the present study to clearly identify the effect of employment on the nighttime peak without investigating the work status of each patient, a low frequency of workers would seems to be associated with the lack of anighttime peak. Furthermore, other studies have found an increased risk for AMI on Monday, likely reflecting the increased physical and mental stress of returning to work after the weekend. 31, 32 However, in this study population there was not a weekly variation of the onset of AMI and although the precise reason for the lack of a Monday peak was not investigated, low frequency of worker may again be associated with this result.
Long-Term Mortality
The long-term mortality rates after AMI in Japan are lower than those in Western countries. 1, 2 In this study, during the follow-up period (mean duration, 4 years), the all-cause mortality rate was 21.4% and furthermore, the 1-year mortality rate after AMI in the total study population was 13.3% and that for in-hospital survivors was 4.3%. In contrast, previous studies of an unselected cohort of patients have shown that 1-year mortality rates after the onset of AMI were 15-30% [33] [34] [35] and approximately 10% after hospital discharge. 36, 37 Although it is difficult to make a simple comparison between present and previous studies, the 1-year mortality rate after AMI in this study seem to be lower than those in previous studies in Western countries.
Predictors of Long-Term Mortality
Predictors of long-term mortality after AMI have been reported from observational studies in Western countries, 34, 35, [38] [39] [40] but because clinical management (the use of invasive procedures 41 and length of admission [42] [43] [44] [45] [46] [47] ), as well as mortality rates in patients with AMI, differ between in Japan and Western countries, 1,2 data from Western countries cannot be directly extrapolated to clinical practice in Japan. Therefore, it is important to accumulate clinical evidence from Japanese patients. There are some previous reports of predictors of long-term mortality in Japanese patients with AMI, [48] [49] [50] [51] [52] but they have several limitations: (1) no multivariate analysis, (2) selected patients, or (3) conducted before the PCI era. The present study of unselected AMI patients in the PCI era revealed predictors of longterm mortality by multivariate analysis. Although this study also has the limitation of being a single-center study, the data more accurately reflect real-world clinical practice in Japan. Previous studies have shown that age, prior myocardial infarction, renal failure, congestive heart failure, and arrhythmia are associated with increased risk of death after AMI, 34, 35, [38] [39] [40] and in the present study, age, prior cerebrovascular disease, renal failure, Killip ≥2, and ventricular tachycardia/fibrillation were independent predictors of worse long-term mortality after AMI, whereas the use of PCI was independently associated with favorable longterm mortality after AMI. Randomized controlled trials have demonstrated that PCI is a more effective reperfusion strategy than intravenous thrombolysis, 53, 54 but it is underused as a therapy for AMI. 55, 56 In the GRACE registry, PCI was less likely to be performed in older patients, 56 even though previous studies have shown that in patients with a high risk of death (ie, older patients), the absolute benefit of PCI may be greater than in the general population. 56, 57 In the present study population, PCI was underused in older patients, which is consistent with results from the previous studies in Western countries. Increased use of PCI may potentially reduce the unnecessarily high mortality rate in elderly patients; however, underutilization of PCI in older patients may be specific to the study hospital. The rate of PCI in Japan was 48-84% in the late 1990s, 8, 52, 58, 59 and between 1998 and 2002 the rate of PCI was 69.9% in this study population, so PCI was not remarkably underused in this hospital compared with other hospitals in Japan during the same period.
Study Limitations
The present study was a single hospital-based analysis of care of AMI in Japan, so our patient population may not reflect the characteristics of the entire Japanese population. Because a community-based or nationwide survey is apparently more representative of the AMI population in Japan, further studies are needed to evaluate the general clinical data for AMI in Japan. In addition, a potential limitation of this study is also the lack of information on well-known secondary preventive therapies (ie, angiotensin-converting enzyme inhibitor, -blockers, aspirin, and HMG CoA reductase inhibitors), which may influence the long-term mortality after AMI. Therefore, further large-sample surveys are needed to examine whether these secondary preventive therapies are effective in Japanese AMI patients.
Conclusions
In this unselected series of AMI patients, the long-term mortality rate was lower than that in previous studies from Western countries. Although PCI is associated with a favorable long-term mortality, it remains underused in a subsets of Japanese patients (ie, elderly and women). Increased use of PCI may additionally reduce the long-term mortality in Japanese AMI patients, but further nation-wide surveys are needed to evaluate the general clinical data for Circulation Journal Vol.69, October 2005 AMI in Japan.
